Cargando…
Norovirus in healthcare settings
PURPOSE OF REVIEW: To provide an overview of the burden of norovirus disease in healthcare settings and the factors responsible for outbreaks in these institutions; to assess progress on interventions aimed at reducing the burden of norovirus disease. RECENT FINDINGS: Norovirus outbreaks in healthca...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154788/ https://www.ncbi.nlm.nih.gov/pubmed/25101555 http://dx.doi.org/10.1097/QCO.0000000000000094 |
_version_ | 1782333478982909952 |
---|---|
author | Iturriza-Gómara, Miren Lopman, Benjamin |
author_facet | Iturriza-Gómara, Miren Lopman, Benjamin |
author_sort | Iturriza-Gómara, Miren |
collection | PubMed |
description | PURPOSE OF REVIEW: To provide an overview of the burden of norovirus disease in healthcare settings and the factors responsible for outbreaks in these institutions; to assess progress on interventions aimed at reducing the burden of norovirus disease. RECENT FINDINGS: Norovirus outbreaks in healthcare settings are driven by confluence of viral diversity, the built environment, and host factors. Some of these characteristics may be modifiable and the target of successful interventions. SUMMARY: Most norovirus outbreaks in hospital and residential care institutions are associated with a particular genotype, known as GII.4. The persistence of norovirus is associated with strain diversity, which is driven by immune evasion and viral adaptation to interaction with a variety of human histo-blood group antigens. The healthcare environment presents serious challenges for control, both because of the physical structure of the built space and the high levels of contact among patient populations who may have compromised hygiene. Increased vulnerability among the populations in healthcare institutions is likely to be multifactorial and may include the following: nutritional status, immunodeficiency or senescence, chronic inflammation, and microbiome alterations. Current control measures are based on general infection control principles, and treatment is mainly supportive and nonspecific. Vaccines and antiviral agents are being developed with promising results, but none are currently available. |
format | Online Article Text |
id | pubmed-4154788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-41547882014-09-18 Norovirus in healthcare settings Iturriza-Gómara, Miren Lopman, Benjamin Curr Opin Infect Dis GASTROINTESTINAL INFECTIONS: Edited by Nicholas J. Beeching and A. Clinton White PURPOSE OF REVIEW: To provide an overview of the burden of norovirus disease in healthcare settings and the factors responsible for outbreaks in these institutions; to assess progress on interventions aimed at reducing the burden of norovirus disease. RECENT FINDINGS: Norovirus outbreaks in healthcare settings are driven by confluence of viral diversity, the built environment, and host factors. Some of these characteristics may be modifiable and the target of successful interventions. SUMMARY: Most norovirus outbreaks in hospital and residential care institutions are associated with a particular genotype, known as GII.4. The persistence of norovirus is associated with strain diversity, which is driven by immune evasion and viral adaptation to interaction with a variety of human histo-blood group antigens. The healthcare environment presents serious challenges for control, both because of the physical structure of the built space and the high levels of contact among patient populations who may have compromised hygiene. Increased vulnerability among the populations in healthcare institutions is likely to be multifactorial and may include the following: nutritional status, immunodeficiency or senescence, chronic inflammation, and microbiome alterations. Current control measures are based on general infection control principles, and treatment is mainly supportive and nonspecific. Vaccines and antiviral agents are being developed with promising results, but none are currently available. Lippincott Williams & Wilkins 2014-10 2014-08-28 /pmc/articles/PMC4154788/ /pubmed/25101555 http://dx.doi.org/10.1097/QCO.0000000000000094 Text en © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | GASTROINTESTINAL INFECTIONS: Edited by Nicholas J. Beeching and A. Clinton White Iturriza-Gómara, Miren Lopman, Benjamin Norovirus in healthcare settings |
title | Norovirus in healthcare settings |
title_full | Norovirus in healthcare settings |
title_fullStr | Norovirus in healthcare settings |
title_full_unstemmed | Norovirus in healthcare settings |
title_short | Norovirus in healthcare settings |
title_sort | norovirus in healthcare settings |
topic | GASTROINTESTINAL INFECTIONS: Edited by Nicholas J. Beeching and A. Clinton White |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154788/ https://www.ncbi.nlm.nih.gov/pubmed/25101555 http://dx.doi.org/10.1097/QCO.0000000000000094 |
work_keys_str_mv | AT iturrizagomaramiren norovirusinhealthcaresettings AT lopmanbenjamin norovirusinhealthcaresettings |